% Expired Patents = 66.7

Forward Citations = 4

Loading Chart...

11 inventors (with patents filed for the assignee):

Vladimir Khazak (4 out of 11 patents)

Igor Astsaturov (2 out of 4 patents)

Chung Shih (2 out of 12 patents)

4. Christoph Burdack (2 out of 4 patents)

5. Lutz Weber (2 out of 16 patents)

6. Ilya G Serebriiskii (1 out of 8 patents)

7. Ilya Serebriiski (1 out of 1 patent)

8. Cedric Kalinski (1 out of 3 patents)

9. Gunther Ross (1 out of 3 patents)

10. Cotïc Kalinski (1 out of 1 patent)

11. Günther F Ross (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 10328050 - C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II inhibition (2019-06-25),

2. 9993458 - Method of treating MYC-amplified tumors with RNA-polymerase II inhibitors (2018-06-12),

3. 9149530 - Compositions and methods for enhancing active agent absorption (2015-10-06),

4. 8426466 - Compositions and methods for enhancing active agent absorption (2013-04-23),

5. 8367699 - Tetrahydro-isoquinolines (2013-02-05),

6. 8163744 - Tetrahydro-isoquinolin-1-ones for the treatment of cancer (2012-04-24),

Company Overview

Nexuspharma, Inc. is a leading pharmaceutical company dedicated to improving healthcare through innovative products and solutions. With a focus on research and development, Nexuspharma is committed to providing high-quality medications that meet the needs of patients worldwide. Our experienced team of scientists and healthcare professionals work tirelessly to bring new treatments to market and improve outcomes for patients. Visit our website to learn more about our company and our products.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#146 in Philadelphia, PA

#1,623 in Pennsylvania

#45,007 in US

Philadelphia, PA, United States of America

Nexuspharma, Inc.

Forward Citations = 4

11 inventors:

Vladimir Khazak (4 out of 11 patents)

Igor Astsaturov (2 out of 4 patents)

Chung Shih (2 out of 12 patents)

4. Christoph Burdack (2 out of 4 patents)

5. Lutz Weber (2 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nexuspharma, Inc.. Retrieved from https://idiyas.com/company/nexuspharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]